The post PSA era: new developments in biomarkers, imaging and biopsy techniques in prostate cancer detection

Wadhwa, Karan; Barrett, Tristan; Kastner, Christof

doi:10.1002/tre.470

Cited by 2 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Aside from PSA there are several blood tests available that may serve as indicators of prostate cancer including PCA-3, the 4K score test, and the Prostate health index, and there is increasing excitement about a potential role for circulating tumour DNA [26]. However, there are currently no blood or urine-based biomarkers that can reliably detect the presence of a high-grade aggressive tumour in the prostate [27]. Realistically, imaging offers the greatest potential for differentiating these more aggressive, lethal cancers.…”

Section: Role Of Imaging In Prostate Cancer:-mentioning

confidence: 99%

The Evolving Role of Multiparametric Mri in Prostate Cancer Work-Up.

Barrett¹

2018

IJAR

Self Cite

View full text Add to dashboard Cite

Prostate cancer is the leading cause of cancer death in men after skin cancer, with an incidence expected to double by 2030 mainly due to the ageing population. However, many more men die with prostate cancer rather than from the disease, highlighting the indolent nature of many tumours. Recently, multiparametric MRI has revolutionised the work-up of prostate cancer, becoming a routine part of clinical practice and migrating earlier in the diagnostic pathway. However, the technique remains challenging, with patient-related factors, intrinsic insensitivity of MRI, protocol differences, and radiologist experienced all combining to limit its overall accuracy. Anatomical T2-weighted imaging is limited by the non-specific nature of its findings and improvements have mainly been driven by the addition of functional sequences such as diffusion-weighted imaging, dynamic contrastenhanced MRI and spectroscopy. In the absence of validated circulating biomarkers, only functional imaging currently offers the potential for further improvements in lesion detection and characterisation, with the additional advantages of providing whole gland coverage of the prostate and being non-invasive. An overview of the evolving role of prostate multiparametric MRI is provided, along with its strengths and weaknesses and an exploration of how it can help overcome limitations in the traditional work-up of patients.

show abstract

Section: Role Of Imaging In Prostate Cancer:-mentioning

confidence: 99%